Xience V
Device Vascular
PDI 08717648064470
General payments
$497,030
Research payments
$168,730
Through program year 2025, $497,030 in general payments and $168,730 in research payments were reported against Xience V (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,750 | 3 |
| 2024 | General | $222,013 | 139 |
| 2023 | General | $108,536 | 241 |
| 2023 | Research | $137,865 | 94 |
| 2022 | General | $166,481 | 579 |
| 2022 | Research | $28,115 | 20 |
Breakdown
The top 5 of 28 recipients; each share is of general payments naming this product in 2024.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
959 general · 117 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.